Search - tctmd.com

Displaying 341 - 360 of 626

Sort: Relevancy | Date

News Daily News

Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis

L.A. McKeown

July 10, 2018

News Daily News

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Caitlin E. Cox

July 10, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Daily News

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

Yael L. Maxwell

July 09, 2018

News Daily News

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Michael O'Riordan

July 06, 2018

News Daily News

New Review Probes Possibility of CVD Prevention Without Aspirin

Michael O'Riordan

July 04, 2018

News Daily News

Open Questions: Cardiology Editors and Academics Mull Data-Sharing Pitfalls and Potential

Shelley Wood

July 04, 2018

News Daily News

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

Todd Neale

July 02, 2018

News Daily News

Once Again, ISCHEMIA Trial Feels the Squeeze

Michael O'Riordan

June 29, 2018

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

Michael O'Riordan

June 27, 2018

News Daily News

Clinical Benefit of Lowering Lp(a) Is Proportional to Its Absolute Reduction: Mendelian Randomization Analysis

Yael L. Maxwell

June 25, 2018

News Daily News

NOACs Carry Lower MI Risk vs Warfarin in Real-world Study

Todd Neale

June 25, 2018

News Industry News

Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device

June 25, 2018

Presentation The Structural Heart Disease Summit 2018

Data Deliverance: Updated PFO Closure for Cryptogenic Stroke Clinical Trial Review and Guidelines

Presenter: John D. Carroll, Brij Maini, Lars Sondergaard

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

Shelley Wood

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

The Vancouver Minimalist Clinical Care Pathway: Updates from the 3M Trial and Evolution to BENCHMARK

Presenter: Vinod H. Thourani, John G. Webb, David A. Wood

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Self-Expanding Single-Operator CENTERA TAVR System: Clinical Data and Plans for the US Pivotal Trial

Presenter: Martin B. Leon

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

Shelley Wood

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: Howard C. Herrmann, Allan Schwartz, Philippe Genereux

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: Howard C. Herrmann, Allan Schwartz, Nicolas M. Van Mieghem

June 22, 2018

Advertisement

Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

New Review Probes Possibility of CVD Prevention Without Aspirin

Open Questions: Cardiology Editors and Academics Mull Data-Sharing Pitfalls and Potential

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

Once Again, ISCHEMIA Trial Feels the Squeeze

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

Clinical Benefit of Lowering Lp(a) Is Proportional to Its Absolute Reduction: Mendelian Randomization Analysis

NOACs Carry Lower MI Risk vs Warfarin in Real-world Study

Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device

Data Deliverance: Updated PFO Closure for Cryptogenic Stroke Clinical Trial Review and Guidelines

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

The Vancouver Minimalist Clinical Care Pathway: Updates from the 3M Trial and Evolution to BENCHMARK

The Self-Expanding Single-Operator CENTERA TAVR System: Clinical Data and Plans for the US Pivotal Trial

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content